Cargando…
The Potential Neuroprotective Effect of Thymoquinone on Scopolamine-Induced In Vivo Alzheimer’s Disease-like Condition: Mechanistic Insights
Background: Alzheimer’s disease (AD) is a common neurodegenerative disorder without effective treatment. Thymoquinone (TQ) has demonstrated potential in exhibiting anti-inflammatory, anti-cancer, and antioxidant characteristics. Despite TQ’s neuroprotection effect, there is a scarcity of information...
Autores principales: | Abo Mansour, Hend E., Elberri, Aya Ibrahim, Ghoneim, Mai El-Sayed, Samman, Waad A., Alhaddad, Aisha A., Abdallah, Mahmoud S., El-Berri, Eman I., Salem, Mohamed A., Mosalam, Esraa M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10534545/ https://www.ncbi.nlm.nih.gov/pubmed/37764343 http://dx.doi.org/10.3390/molecules28186566 |
Ejemplares similares
-
Chronotherapeutic neuroprotective effect of verapamil against lipopolysaccharide-induced neuroinflammation in mice through modulation of calcium-dependent genes
por: Mosalam, Esraa M., et al.
Publicado: (2022) -
Pentoxifylline as an adjunctive in treatment of negative symptoms in chronic schizophrenia: A double‐blind, randomized, placebo‐controlled trial
por: Abdallah, Mahmoud S., et al.
Publicado: (2022) -
Investigation of the phytochemical composition, antioxidant, antibacterial, anti-osteoarthritis, and wound healing activities of selected vegetable waste
por: Salem, Mohamed A., et al.
Publicado: (2023) -
Evaluating the safety and efficacy of the leukotriene receptor antagonist montelukast as adjuvant therapy in obese patients with type 2 diabetes mellitus: A double-blind, randomized, placebo-controlled trial
por: El-Khateeb, Eman, et al.
Publicado: (2023) -
Thymoquinone: A Tie-Breaker in SARS-CoV2-Infected Cancer Patients?
por: Elgohary, Sawsan, et al.
Publicado: (2021)